The company was founded in 2006 and is a wholly-owned subsidiary of Hong Kong Hang Seng Index Stock Pharmaceutical Group. In 2019, Shiyao Innovation registered on the A-share GEM and became the first share of a Chinese red chip company to split back to A. The company's main business is R&D, production and sales of functional ingredients, health foods, and specialty foods. The main products are functional raw materials, mainly caffeine, acarbose, anhydrous glucose, etc. Health foods are mainly Guowekang vitamin C tablets and B vitamin tablets. The company has received honors such as the Hebei Enterprise Technology Center, the Hebei Science and Technology Achievement Award, and the 2018 Hebei Patent Award Excellence Award.
Clinical Trials
0
0 active
Approvals
6
Total approvals
Agencies
1
Regulatory bodies
Founded
2006
No trial phase data available
No trial data available
No trial data available